Norwegian Cruise Line is making a change to its onboard drinks package relating to its private island. "As we look to transform the on-island experience, we have evaluated our policies and made the ...
TotalEnergies has agreed to sell its sustainable consultancy and solutions unit, GreenFlex, to French engineering and consulting firm Oteis, in a move that underscores the oil major’s strategy to ...
Jul 17, 2025; Indianapolis, IN, USA; Angel Reese arrives on the Orange Carpet to start the 2025 WNBA All-Star weekend at Indiana Convention Center. Mandatory Credit: Trevor Ruszkowski-Imagn Images The ...
CHARLOTTE, N.C. -- Carolina Panthers running back Chuba Hubbard said he expects to play against the New York Jets on Sunday, but he isn't sure in what capacity after missing the past two games with a ...
Change could well be the name of the game in fantasy football over these next 20 days. The NFL trade deadline arrives at 4 p.m. ET on Nov. 4, and it represents one of those rare opportunities in ...
Manesar (Gurugram): On its Raising Day, the National Security Guard (NSG) showcased a high-intensity mock drill simulating a terrorist attack inside a college campus. The exercise recreated a hostage ...
Jul 12, 2023; Los Angeles, CA, USA; LSU basketball player Angel Reese arrives on the red carpet before the 2023 ESPYS at the Dolby Theatre. Mandatory Credit: Kirby Lee-Imagn Images WNBA superstar ...
Argenica shares surge more than 20% on further phase II trial results and news of a follow-on phase 2b study Telix shares jump 17% on robust September quarter revenue from its prostate cancer imaging ...
With a background in journalism and counseling, Penny Min blends analytical research with real-world insight to help readers make informed financial decisions. At Forbes Marketplace, she specializes ...
The European Union is poised to toughen its trade stance towards China, with the bloc set to insist that Chinese investors in Europe transfer technology to local firms, and as it formulates a response ...
Diagnostic play Nexsen surges 47% on its ASX debut, after a well-supported raising Audeara has entered the Japanese market, we hear FDA drug approvals plunge Shares in our latest ASX biotech entrant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results